Navigation Links
Anti-Retrovirals in Africa, not a distant dream

Ranbaxy Laboratories (India) has entered into a joint venture with a South African company that will support Ranbaxy’s key agenda of enabling antiretroviral drugs in Africa. //A joint venture between Ranbaxy and South Africa based Community Investment Holdings has been signed, that will give authority for this company to sell the drugs in Africa. The CEO of Ranbaxy South Africa, Desmond Brothers, conveyed that this venture will permit the company to make the drugs available at a low cost.

Ranbaxy will retain 70% of the venture, called Sonke Pharmaceuticals, in charge of marketing the products under the brand name 'Sonke'. Governments, retail pharmacists, HIV/AIDS disease management companies, nongovernmental organizations and independent community treatment organizations in South Africa, Botswana and Namibia, will be the contact points for sales of the antiretroviral drugs.


'"/>




Page: 1

Related medicine news :

1. Anti-Retrovirals Capable of Halting Mental Illness in HIV Patients
2. Unilever And World Dental Federation Team Up To Improve Oral Health In North Africa, Middle East and Turkey
3. UC Researchers: Low-cost malaria cure will not be a distant dream
4. Rats dream about running mazes...
5. Adult And Children Cravings: Sleep and More Sleep is a dream!
6. UC Researchers: Low-cost malaria cure will not be a distant dream
7. "Daydreaming" Network Fails In Autism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 2016 , ... World Patent Marketing , a vertically ... automotive invention that improves the storage features of a pick up truck. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Over the next five ...
(Date:4/29/2016)... Arizona (PRWEB) , ... April 29, 2016 , ... ... Healing and Spiritual Awakening , announces the addition Onnit brand Alpha BRAIN and ... The addition of Onnit brain and mood optimization products to the store is ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... Philadelphia, PA (PRWEB) , ... April 29, 2016 ... ... Pennsylvania announced that student team BioCellection won the $30,000 Perlman Grand Prize of ... Impact Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Dr. ... cosmetic dental treatments to improve smiles. Cosmetic dentistry is a fast-growing field as more ... This offer allows patients to learn more about the options currently available to them ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
(Date:4/27/2016)...   , ... le trimestre, soutenu par une croissance de +42% ... de +16% des ventes aux hôpitaux et cliniques  ... (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de Cellvizio®, ... chiffre d,affaires pour le premier trimestre clos au ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology: